The fresh energy brought by the revitalized research attention offers an opportunity to more closely integrate novel drug discovery, residue monitoring, and ...

PORTLAND, IN, UNITED STATES, July 3, 2025 /EINPresswire.com/ -- According to the report, the global animal model market was valued at $1.9 billion in 2022 and is estimated to reach $3.6 billion by ...

UB scientists Ram Samudrala, PhD, and Zackary M. Falls, PhD, talk about the new platform to make drug discovery faster and less expensive while also being safe and effective.

Recursion Pharmaceuticals RXRX is redefining the traditional model of drug discovery by harnessing the power of artificial ...

Advances in computational biology, bioinformatics, artificial intelligence (AI), and high-performance computing have dramatically accelerated the ...

Optibrium, a leading developer of software and AI solutions for molecular design, today announced its partnership with ...

While biopharmaceutical technologies have made substantial strides in treating diseases, drug research and development ...

Here we use cryogenic electron microscopy to determine the structure of TbAQP2 from Trypanosoma brucei, bound to either the substrate glycerol or to the sleeping sickness drugs, pentamidine or ...

Shandong University developed an advanced AI framework that predicts molecular properties in seconds with high accuracy and minimal computational ...

A review from Xidian University shows that advanced computational algorithms—from neural networks and matrix methods to recommendation engines and ...

SCHINDELLEGI, SCHWYZ, SWITZERLAND, June 30, 2025 /EINPresswire.com/ -- AsedaSciences, a pioneer in human-relevant toxicity profiling, machine learning integration and data visualization for chemical ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the best AI stocks to buy according to hedge funds. Earlier on June 6, ...